UroGen Pharma Ltd. (URGN)
24.87
+2.33
(+10.34%)
USD |
NASDAQ |
Apr 20, 16:00
25.00
+0.13
(+0.52%)
After-Hours: 20:00
UroGen Pharma Total Assets (Quarterly) : 200.46M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Terns Pharmaceuticals, Inc. | 1.025B |
| Cogent Biosciences, Inc. | 937.61M |
| Puma Biotechnology, Inc. | 217.67M |
| Zymeworks, Inc. | 346.53M |
| Xeris Biopharma Holdings, Inc. | 392.94M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 305.93M |
| Shareholders Equity (Quarterly) | -105.47M |
| Debt to Equity Ratio | -1.233 |
| Current Ratio | 4.008 |
| Net Debt Paydown Yield | -0.13% |